Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: A randomized, placebo-controlled, clinical study

Critical Care Medicine

Volumn 38, Issue 5, 2010, Pages 1284-1290

  Westermaier, Thomas ^a,b   Stetter, Christian ^a   Vince, Giles H ^a   Pham, Mirko ^a   Tejon, Jose Perez ^a   Eriskat, Jörg ^a   Kunze, Ekkehard ^a   Matthies, Cordula ^b   Ernestus, Ralf Ingo ^b   Solymosi, Laszlo ^a   Roosen, Klaus ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Delayed cerebral infarction; Intravenous; Magnesium; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

LOESNESIUM; MAGNESIUM; MAGNESIUM SULFATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRADYCARDIA; BRAIN ARTERY ANEURYSM; BRAIN INFARCTION; BRAIN VASOSPASM; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGITAL SUBTRACTION ANGIOGRAPHY; DOPPLER ECHOGRAPHY; DRUG MEGADOSE; FEMALE; FLUSHING; GLASGOW OUTCOME SCALE; HEART RATE; HUMAN; HYPOCALCEMIA; HYPOTENSION; INTENSIVE CARE UNIT; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SUBARACHNOID HEMORRHAGE; TETANY; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 77951622468     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181d9da1e     Document Type: Article

References (34)

1. van Gijn J, Kerr RS, Rinkel GJ: Subarachnoid haemorrhage. Lancet 2007; 369:306-318
2. Cahill J, Zhang JH: Subarachnoid hemorrhage: Is it time for a new direction? Stroke 2009; 40:86-87
3. Pluta RM, Hansen-Schwartz J, Dreier J, et al: Cerebral vasospasm following subarachnoid hemorrhage: Time for a new world of thought. Neurol Res 2009; 31:151-158
4. Peruche B, Krieglstein J: Mechanisms of drug actions against neuronal damage caused by ischemia - An overview. Prog Neu-ropsychopharmacol Biol Psychiatry 1993; 17:21-70
5. Nowak L, Bregestovski P, Ascher P, et al: Magnesium gates glutamate-activated channels in mouse central neurones. Nature 1984; 307:462-465
6. Kristal BS, Dubinsky JM: Mitochondrial permeability transition in the central nervous system: Induction by calcium cycling-dependent and-independent pathways. J Neurochem 1997; 69:524-538
7. Schanne FA, Gupta RK, Stanton PK: 31P-NMR study of transient ischemia in rat hip-pocampal slices in vitro. Biochim Biophys Acta 1993; 1158:257-263
8. van den Bergh WM, Algra A, van der Sprenkel JW, et al: Hypomagnesemia after aneurysmal subarachnoid hemorrhage. Neurosurgery 2003; 52:276-281
9. Schmid-Elsaesser R, Kunz M, Zausinger S, et al: Intravenous magnesium versus nimodip-ine in the treatment of patients with aneu-rysmal subarachnoid hemorrhage: A randomized study. Neurosurgery 2006; 58: 1054-1065
10. Stippler M, Crago E, Levy EI, et al: Magnesium infusion for vasospasm prophylaxis after subarachnoid hemorrhage. J Neurosurg 2006; 105:723-729
11. van den Bergh WM, Algra A, van Kooten F, et al: Magnesium sulfate in aneurysmal sub-arachnoid hemorrhage: A randomized controlled trial. Stroke 2005; 36:1011-1015
12. Boet R, Chan MT, Poon WS, et al: Intravenous magnesium sulfate to improve outcome after aneurysmal subarachnoid hemorrhage: Interim report from a pilot study. Acta Neu-rochir Suppl 2005; 95:263-264
13. Veyna RS, Seyfried D, Burke DG, et al: Magnesium sulfate therapy after aneurysmal sub-arachnoid hemorrhage. J Neurosurg 2002; 96:510-514
14. Wong GK, Chan MT, Boet R, et al: Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: A prospective randomized pilot study. J Neurosurg Anes-thesiol 2006; 18:142-148
15. Westermaier T, Zausinger S, Baethmann A, et al: Dose finding study of intravenous magnesium sulphate in transient focal cerebral ischemia in rats. Acta Neurochir (Wien) 2005; 147:525-532
16. Pham M, Johnson A, Bartsch AJ, et al: CT perfusion predicts secondary cerebral infarction after aneurysmal subarachnoid hemorrhage. Neurology 2007; 69:762-765
17. Jestaedt L, Pham M, Bartsch AJ, et al: The impact of balloon angioplasty on the evolution of vasospasm-related infarction after an-eurysmal subarachnoid hemorrhage. Neuro-surgery 2008; 62:610-617
18. Dorhout MS, van den Bergh WM, Algra A, et al: Achieved serum magnesium concentrations and occurrence of delayed cerebral ischaemia and poor outcome in aneurysmal subarachnoid haemorrhage. J Neurol Neuro-surg Psychiatry 2007; 78:729-731
19. Boet R, Mee E: Magnesium sulfate in the management of patients with Fisher Grade 3 subarachnoid hemorrhage: A pilot study. Neurosurgery 2000; 47:602-606
20. Frontera JA, Fernandez A, Schmidt JM, et al: Defining vasospasm after subarachnoid hemorrhage: What is the most clinically relevant definition? Stroke 2009; 40:1963-1968
21. van Norden AG, van den Bergh WM, Rinkel GJ: Dose evaluation for long-term magnesium treatment in aneurysmal subarachnoid haemorrhage. J Clin Pharm Ther 2005; 30: 439-442
22. Muroi C, Terzic A, Fortunati M, et al: Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: A randomized, placebo-controlled, dose-adapted trial. Surg Neurol 2008; 69: 33-39
23. van de Water JM, van den Bergh WM, Hoff RG, et al: Hypocalcaemia may reduce the beneficial effect of magnesium treatment in aneurysmal subarachnoid haemorrhage. Magnes Res 2007; 20:130-135
24. van den Bergh WM, van de Water JM, Hoff RG, et al: Calcium homeostasis during magnesium treatment in aneurysmal subarach-noid hemorrhage. Neurocrit Care 2008; 8:413-417
25. Macdonald RL, Kassell NF, Mayer S, et al: Clazosentan to overcome neurological ischemia and infarction occurring after sub-arachnoid hemorrhage (CONSCIOUS-1): Randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 2008; 39:3015-3021
26. Miyazaki T, Ohta F, Moritake K, et al: The key to improving prognosis for aneurysmal sub-arachnoid hemorrhage remains in the pre-hospitalization period. Surg Neurol 2006; 65: 360-365
27. Ruiz-Sandoval JL, Cantu C, Chiquete E, et al: Aneurysmal subarachnoid hemorrhage in a Mexican multicenter registry of cerebrovas-cular disease: The RENAMEVASC study. J Stroke Cerebrovasc Dis 2009; 18:48-55
28. Ogungbo B, Gregson BA, Blackburn A, et al: Trends over time in the management of sub-arachnoid haemorrhage in Newcastle: Review of 1609 patients. Br J Neurosurg 2001; 15:388-395
29. Jones TH, Morawetz RB, Crowell RM, et al: Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 1981; 54: 773-782
30. Pickard JD, Murray GD, Illingworth R, et al: Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 1989; 298:636-642
31. Dorhout MS, Rinkel GJ, Feigin VL, et al: Calcium antagonists for aneurysmal sub-arachnoid haemorrhage. Cochrane Database Syst Rev 2007; CD000277
32. Wong GK, Chan MT, Poon WS, et al: Magnesium therapy within 48 hours of an aneurys-mal subarachnoid hemorrhage: Neuro-panacea. Neurol Res 2006; 28:431-435
33. Dorhout MS: Magnesium in aneurysmal sub-arachnoid hemorrhage (MASH II) phase III clinical trial MASH-II study group. Int J Stroke 2008; 3:63-65
34. Zhao XD, Zhou YT, Zhang X, et al: A meta analysis of treating subarachnoid hemorrhage with magnesium sulfate. J Clin Neu-rosci 2009